Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_1
3
50%
Ph phase_3
2
33%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (60.0%)
Phase 32 (40.0%)

Trials by Status

unknown117%
active_not_recruiting117%
completed467%

Recent Activity

1 active trials
Showing 5 of 6
active_not_recruitingphase_3

Linerixibat Long-term Safety, and Tolerability Study

NCT04167358
completedphase_3

Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

NCT04950127
unknown

Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)

NCT05448170
completedphase_1

Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls

NCT05393076
completedphase_1

Food Effect Study of Linerixibat Tablets in Healthy Adult Participants

NCT05435170
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04167358Phase 3

Linerixibat Long-term Safety, and Tolerability Study

Active Not Recruiting
NCT04950127Phase 3

Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Completed
NCT05448170

Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)

Unknown
NCT05393076Phase 1

Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls

Completed
NCT05435170Phase 1

Food Effect Study of Linerixibat Tablets in Healthy Adult Participants

Completed
NCT05133830Phase 1

Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6